Get started
Author

Stefania Orini

European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
2024 · Giovanni B Frisoni, Cristina Festari, et al. · The Lancet Neurology · 183
PDF
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
2018 · for the EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, Zuzana Walker, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 138
PDF
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Peter J. Nestor, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 119
PDF
Clinical utility of FDG-PET for the clinical diagnosis in MCI
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Javier Arbizu, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 90
PDF
What Role Can Process Mining Play in Recurrent Clinical Guidelines Issues? A Position Paper
2020 · Roberto Gatta, Mauro Vallati, et al. · International Journal of Environmental Research and Public Health · 76
PDF
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study
2020 · Alessandro Morandi, Marco Inzitari, et al. · Journal of the American Medical Directors Association · 55
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
2018 · For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Flavio Nobili, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 55
PDF
Living Environment and Mobility of Older Adults
2010 · M. Elaine Cress, Stefania Orini, et al. · Gerontology · 51
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Alexander Drzezga, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 43
Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes
2007 · S. Bossoni, G. Mazziotti, et al. · Age and Ageing · 39
European consensus for the diagnosis of MCI and mild dementia: Preparatory phase
2022 · Cristina Festari, Federico Massa, et al. · Alzheimer s & Dementia · 38
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Femke Bouwman, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 32
PDF
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Federica Agosta, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 31
Homocysteine and disability in hospitalized geriatric patients
2004 · Alessandra Marengoni, Stefania Cossi, et al. · Metabolism · 31
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
2018 · for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Marina Boccardi, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 30
Clinical Guidelines: A Crossroad of Many Research Areas. Challenges and Opportunities in Process Mining for Healthcare
2019 · Roberto Gatta, Mauro Vallati, et al. · Lecture notes in business information processing · 28
Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer’s disease
2020 · Lorenzo Pini, Cristina Geroldi, et al. · Brain Imaging and Behavior · 26
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
2024 · Matteo Cotta Ramusino, Federico Massa, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 24
GEN-RWD Sandbox: bridging the gap between hospital data privacy and external research insights with distributed analytics
2024 · Benedetta Gottardelli, Roberto Gatta, et al. · BMC Medical Informatics and Decision Making · 20
PDF
The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017
2021 · Alberto Zucchelli, F. Manzoni, et al. · Aging Clinical and Experimental Research · 16
PDF
Psychobiological effects of an eHealth psychoeducational intervention to informal caregivers of persons with dementia: a pilot study during the COVID-19 pandemic in Italy
2023 · Claudio Singh Solorzano, Nadia Cattane, et al. · Aging Clinical and Experimental Research · 8
PDF
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study
2022 · Chiara Sidoli, Antonella Zambon, et al. · Aging Clinical and Experimental Research · 8
PDF
Treatment With Metformin Is Protective Against Limitations in Instrumental Activities of Daily Living in Older Subjects With Type 2 Diabetes Mellitus
2009 · Gherardo Mazziotti, Simonetta Bossoni, et al. · Journal of the American Geriatrics Society · 6
PDF
Process Mining in Healthcare: Challenges and Promising Directions
2022 · Roberto Gatta, Stefania Orini, et al. · Brain informatics and health · 5
The new therapy for Alzheimer’s disease: from a hope for a few to a false hope?
2022 · Stefania Orini, Cristina Geroldi, et al. · Aging Clinical and Experimental Research · 4
Works count: 63
Citation count: 1,174
H-index: 19
I10-index: 20
Year
Topic
Type